1. Search Result

Search Result

Results for "920113-02-6" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-16559A

    P276-00 (free base)

    CDK Cancer
    Riviciclib (P276-00 free base) is a potent cyclin-dependent kinase (CDK) inhibitor, which inhibits CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively. Riviciclib shows antitumor activity on cisplatin-resistant cells.